Cabenuva seemed to be a cure for adherence issues while treating HIV, so why is accessing it so hard?
Dr. Carly Floyd joins the podcast to discuss issues with Cabenuva billing that has negatively impacted many patients, providers and clinics around the US. What seems like it should be simple approval process has turned into a medical billing nightmare that limits patients access, costs some clinics to lose money and has been a major issue with how we treat HIV. Increased opacity is never good in healthcare billing.
Join AAHIVM here:
https://aahivm.org/
Read more on Cabenuva issues here:
https://aahivm.org/wp-content/uploads/2021/03/Long-Acting-ARVs-_Final-2-25-21_PDF.pdf
https://www.floridahealth.gov/diseases-and-conditions/aids/adap/_documents/FINAL5BarrierstoLA-ARVsResourceSheetforProviders.pdf
http://aidsnet.org/wp-content/uploads/2021/11/3-cabenuva-nov-19-2021-version.pdf
Reach out to Dr. Floyd here: https://www.linkedin.com/in/carlycloudfloyd/
view more